For example: Apple Inc, UTIL, Aluminum
TherapeuticsMD, Inc.
NASDAQ:TXMD
Market Close 04/19
1.16 USD -0.02 (-1.69%)
OPEN:
1.17
DAY RANGE:
1.12 - 1.18
PE:
-3.61
PB:
9.29
PS:
33.74
WTD % -1.69
MTD % -13.43
QTD % -13.43
YTD % -4.13
* Updated at market close
TherapeuticsMD, Inc. (NASDAQ:TXMD) opened on Apr 19, 2021 at 1.17 USD and decreased by -1.69%. The intraday price range was 1.12 - 1.18 USD and eventually ended the session at 1.16 USD. The stock trade volume was 8.07 M shares. The company's 52-week range is 0.90 - 2.75 USD.
Trading Statistics (Market Close Apr 19, 2021)
Market Cap 316.46 M
Outstanding Stock 237.88 M
Dividend 0.00
Dividend Yield 0.00
EPS -0.72
YTD Change -4.13%
52 Week's Range 0.90 - 2.75
Key Ratio & Margins (Market Close Apr 19, 2021)
Price/Earning -3.61
Price/Book Value 9.29
Price/Sales 33.74
ROA -
ROE -
Debt/Equity 29.46
Company Self Description
TherapeuticsMD, Inc. operates as a women's health care product company. The company also manufactures and distributes branded and generic prescription prenatal vitamins under the vitaMedMD and BocaGreenMD brands. It was founded in 2008 and is headquartered in Boca Raton, Florida, United States.
Business Information
TherapeuticsMD, Inc.
Sector Health Care
Industry Pharmaceuticals
Exchange NASDAQ
Top Competitors (Market Close Apr 19, 2021)
  TXMD FULC SLGL VRCA
Daily Change (%) -1.69 -1.65 -0.42 0
WTD (%) -1.69 -1.65 -0.42 0
MTD (%) -13.43 -3.74 15.51 -16.24
QTD (%) -13.43 -3.74 15.51 -16.24
YTD (%) -4.13 -3.16 46.07 10.25
52-Week Change (%) 21.56 3.28 74.60 15.15
Stock Performance (Market Close Apr 19, 2021)
  TXMD FULC SLGL VRCA
Daily Change (%) -1.69 -1.65 -0.42 0
WTD (%) -1.69 -1.65 -0.42 0
MTD (%) -13.43 -3.74 15.51 -16.24
QTD (%) -13.43 -3.74 15.51 -16.24
YTD (%) -4.13 -3.16 46.07 10.25
52-Week Change (%) 21.56 3.28 74.60 15.15
Key Fundamentals (Market Close Apr 19, 2021)
  TXMD FULC SLGL VRCA
Market Cap 316.46 M 311.43 M 328.91 M 328.23 M
Revenue Growth - - - -
Net Income Growth - - - -
Profit Margin -913.10% - -24,963.60% 0.00
P/E Ratio -3.61 - -3.34 -12.10
Price to Sales Ratio 33.74 - 833.82 0
Price to Book Ratio 9.29 - 1.78 2.34
Enterprise Value to EBITDA -6.19 - -5.20 -8.30
ROA - - -75.80% -30.50%
ROE - - -574.50% -31.60%
Debt/Equity 29.46 - 0.09 0.03
Asset Turnover Ratio 0.09 - 0.00 0
Current Ratio 4.55 - 13.48 36.80
Dividend Yield 0.00 - - 0
in USD
  Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015
Revenue 16.10 M 16.78 M 19.36 M 20.14 M
Cost Of Revenue 2.74 M 2.64 M 4.19 M 4.51 M
Gross Profit 13.36 M 14.14 M 15.17 M 15.64 M
Selling General & Administrative Expenses 115.99 M 57.70 M 51.35 M 28.72 M
Research & Development 27.30 M 33.85 M 53.94 M 72.04 M
Operating Income -130.22 M -77.63 M -90.25 M -85.19 M
Net Income -132.62 M -76.93 M -89.88 M -85.08 M
EPS -0.59 -0.37 -0.46 -0.49
Diluted EPS -0.59 -0.37 -0.46 -0.49
  Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018
Revenue 6.08 M 3.95 M 5.09 M 3.47 M
Cost Of Revenue 1.25 M 762,827.00 950,750.00 699,118.00
Gross Profit 4.83 M 3.18 M 4.14 M 2.77 M
Selling General & Administrative Expenses 41.39 M 34.86 M 35.41 M 30.35 M
Research & Development 4.96 M 6.32 M 6.75 M 6.71 M
Operating Income -41.64 M -38.11 M -38.12 M -34.36 M
Net Income -55.24 M -39.51 M -39.39 M -35.61 M
EPS -0.23 -0.16 -0.17 -0.16
Diluted EPS -0.23 -0.16 -0.17 -0.16
in USD
  Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015
Total Current Assets 186.78 M 139.55 M 139.41 M 70.68 M
Cash & Cash Equivalents 161.61 M 127.14 M 131.53 M 64.71 M
Total Assets 211.98 M 143.23 M 142.47 M 73.73 M
Total Current Liabilities 41.08 M 13.32 M 14.98 M 10.67 M
Total Liabilities 114.46 M 13.32 M 14.98 M 10.67 M
Shareholder's Equity 97.52 M 129.91 M 127.49 M 63.06 M
Outstanding Stock 237.88 M 216.43 M 196.58 M 177.85 M
  Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018
Total Current Assets 216.46 M 152.63 M 186.78 M 211.69 M
Cash & Cash Equivalents 182.85 M 122.88 M 161.61 M 190.00 M
Total Assets 246.55 M 181.89 M 211.98 M 236.75 M
Total Current Liabilities 41.88 M 44.97 M 41.08 M 29.28 M
Total Liabilities 238.46 M 121.20 M 114.46 M 102.54 M
Shareholder's Equity 8.09 M 60.69 M 97.52 M 134.22 M
Outstanding Stock 241.22 M 241.16 M 237.88 M 216.83 M
in USD
  Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015
Net Cash Flow from Operations -106.81 M -76.16 M -69.14 M -79.04 M
Capital Expenditures -217,040.00 -61,817.00 -396,154.00 -165,257.00
Net Cash Flow from Investing Activities -21.50 M -827,108.00 -1.26 M -584,361.00
Net Cash Flow from Financial Activities 162.79 M 72.58 M 137.23 M 92.97 M
Free Cash Flow -107.03 M -76.22 M -69.54 M -79.21 M
  Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018
Net Cash Flow from Operations -50.51 M -76.16 M -69.14 M -79.04 M
Capital Expenditures -830,086.00 -262,418.00 -150,745.00 -20,575.00
Net Cash Flow from Investing Activities -1.21 M -665,914.00 -671,171.00 -20.33 M
Net Cash Flow from Financial Activities 111.69 M 100,107.00 429,895.00 90.02 M
Free Cash Flow -51.34 M -38.43 M -28.30 M -34.09 M
Key Ratios (Market Close Apr 19, 2021)
Valuation Ratios 2021 2020 2019 2018
P/E Ratio -3.61 -7.61 -6.46 -12.62
Price to Sales Ratio 33.74 72.13 53.25 98.88
Price to Book Ratio 9.29 10.06 8.90 29.25
Enterprise Value to EBIT -6.00 -15.00 -11.00 -21.00
Enterprise Value to EBITDA -6.19 -15.11 -11.00 -20.74
Profitability Ratios 2021 2020 2019 2018
Revenue Growth - - - -
Net Income Growth - - - -
ROA - - - -71.30%
ROE - - - -127.30%
Liquidity Ratios 2021 2020 2019 2018
Working Capital 145.70 M 126.23 M 124.43 M 60.01 M
Current Ratio 4.55 10.48 9.31 6.63
Efficiency & Capital Structure Ratios 2021 2020 2019 2018
Debt Equity Ratio 29.46 0.10 0.12 0.17
Asset Turnover Ratio - - - 0.09
Scratchpad (max of 30 tickers)
Symbol Last Price Change
Empty Scratchpad
Portfolio (max of 30 tickers)
Login is required to view your portfolio.